Search results
Millions of Americans in insulin deserts worry that recent price reductions could one day disappear
Black Hills FOX· 2 days agoCharlene Davis sleeps on her living room floor in Atlanta to help ease her back pain and make it...
Amazon expands drug subscription program to Medicare members
Healthcare Dive via Yahoo Finance· 1 day agoRxPass is now available to more than 50 million Medicare members after Amazon brought it into...
Gateway - Quartz
Quartz· 10 hours agoNovo Nordisk stock surged Thursday morning, reaching an all-time high and surpassing Tesla’s market capitalization. The Denmark-based pharmaceutical giant known for its diabetes< ...
Gateway - Quartz
Quartz· 9 hours ago“Lilly’s first quarter performance reflects solid year-over-year revenue growth with strong sales of Mounjaro... CEO David A. Ricks in a press release. The company’s revenue grew 26% year over ...
Massive surge in pre-diabetes as high blood sugar levels create timebomb
Daily Express· 6 days agoA record 3.6million people are at high risk of developing diabetes as the nation battles an obesity...
Study hints at tools to prevent diabetes associated with antipsychotic medications
Medical Xpress· 6 days agoNew University of Pittsburgh research points to a potential approach to reducing the risk of ...
Gateway - Quartz
Quartz· 16 hours agoA new study found that Novo Nordisk’s nearly $1,000 per month diabetes medication Ozempic can be produced for less than $5 a month. Novo Nordisk and Johnson & Johnson both ...
Ashley Benson Denies Using Ozempic, Says She Worked 'Very Hard' to Get Her 'Body Back' After Giving...
People via Yahoo News· 1 day agoOn Monday, June 17, Benson, 34, clapped at comments accusing her of being on the type 2 diabetes ...
How to lose weight safely as doctor warns of Ozempic misuse
Yahoo Life UK· 24 hours agoHowever, a recent investigation from the BBC found that online pharmacies are selling the drugs for...
Gateway - Quartz
Quartz· 11 hours agoJPMorgan Chase’s asset management division just finished raising a $500 million biotech fund, and its managers are looking at weight loss drug investments. Johnson & Johnson ...